Hoyoung Huh's most recent trade in Pliant Therapeutics Inc was a trade of 30,000 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Hoyoung Huh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 30,000 | - | - | Common Stock (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 892,857 | 892,857 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 892,857 | 892,857 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Hoyoung Huh | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 892,857 | 4,695,854 (0%) | 0% | 1.1 | 1,000,000 | American Depositary Shares representing Ordinary Shares |
| Pliant Therapeutics Inc | Hoyoung Huh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | |
| Pliant Therapeutics Inc | Hoyoung Huh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Hoyoung Huh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Hoyoung Huh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 13,286 | 13,286 | - | - | Stock Option (right to buy) |